SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AXYS Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: TomOrt who wrote (50)3/5/1998 9:50:00 PM
From: Steve Lokness  Respond to of 455
 
Thanks Tom;

Great News. Those of us who already hold AXPH are strong believers. We just have to wait for the analyst to come around. They will.

Good Investing;

Steve



To: TomOrt who wrote (50)3/7/1998 9:34:00 AM
From: Zirdu  Respond to of 455
 
The story on the Vector upgrade also stated that the analyst found AxyS stock valuation "compelling," and that he put a one year price target of $18 on the stock.

I'll take $18! Though I have been thinking that I bought into this one a year or so early.

RR


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News